. 2023 Feb 18;13(6):2425–2463. doi: 10.1016/j.apsb.2023.02.007
© 2023 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 14.
Examples of class IIa HDACs selective inhibitors.